What Humax Pharmaceutical does

Humax Pharmaceutical S.A. is a Colombian pharmaceutical laboratory and wholly-owned subsidiary (filial) of Bausch Health Companies Inc., headquartered in La Estrella, Antioquia. The company was founded in 2002 and has operated for over 22 years in the Colombian market, manufacturing and commercializing branded generic pharmaceutical products across multiple therapeutic areas including dermatology (Sulzinc, Caladryl), allergy (Fexodina), pain management (Naprofen, Neuronox), antifungals (Terbifin), and nutritional supplements (Bedoyecta). Its core technology is pharmaceutical formulation and manufacturing, augmented by a corporate Pharmacovigilance Unit operating under INVIMA and international standards for adverse event reporting and drug safety monitoring. The company employs 251-500 people and focuses on delivering effective, reliable medications at reasonable prices for the general Colombian patient population, with a stated commitment to therapeutic areas "few in the industry consider."

Humax operates a traditional pharmaceutical sales-led go-to-market model, distributing products through pharmacy and healthcare networks across Colombia on a one-time-purchase basis. Its customer base is the broad Colombian patient population (horizontal segmentation), reached via distributor/wholesale channels and supported by organic social media presence (LinkedIn, Instagram, Facebook) and a corporate blog. The company is governed under Colombian corporate law as a Sociedad Anónima (S.A.) and is subject to INVIMA regulatory oversight. Strategic alignment with its Bausch Health parent is evidenced by visits from global VPs of Quality and Manufacturing and structured Town Hall alignment events. Recent operational emphasis has been on internal workforce development, including 250+ employee promotions across 2023-2025, English language certification via Idiomas EAFIT, and a mentoring program with Aristos Consultores that has trained 30+ mentors.

Name

Humax Pharmaceutical

Legal name

HUMAX PHARMACEUTICAL S.A.

Website

https://humax.com.co

Company type

Public

Founded year

2002

Operating status

Operating

Headcount range

251–500 employees

Short description

Humax Pharmaceutical S.A. is a Colombian subsidiary of Bausch Health Companies Inc. that manufactures and distributes branded generic pharmaceuticals across dermatology, allergy, pain management, and supplements, serving the general Colombian patient population through pharmacy and healthcare networks.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Branded generic pharmaceuticals
• Pharmaceutical manufacturing
• Dermatology medications
• Over-the-counter drugs
• Nutritional supplements

Headquarters

HQ city

La Estrella

HQ country

Colombia

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products Sales: Manufacturing, distribution and sale of branded generic pharmaceutical products including over-the-counter and prescription medications across multiple therapeutic areas including dermatology, allergy, pain management, and nutritional supplements

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Humax Pharmaceutical manufactures, distributes, and sells branded generic pharmaceutical products for the Colombian market across multiple therapeutic areas including dermatology, allergy, pain management, neurology, antifungals, and nutritional supplements. Its portfolio includes established brands such as Caladryl, Sulzinc, Fexodina, Naprofen, Neuronox, Terbifin, and Bedoyecta, sold through pharmacy and healthcare outlets at affordable prices.

Product overview

Humax Pharmaceutical is a Colombian pharmaceutical company and subsidiary of Bausch Health Companies Inc. The company manufactures and commercializes a portfolio of pharmaceutical products including medications for dermatological conditions (Caladryl), anti-inflammatory treatments (Naprofen), antihistamines (Fexodina), antifungals (Terbifin), topical treatments (Sulzinc), neurological products (Neuronox), and vitamins/supplements (Bedoyecta). With over 22 years of history, the company is committed to providing effective and reliable medications at reasonable prices, focusing on products that address important areas of human health.

Differentiator

Problem solved

Functional benefit

Brands

• Sulzinc: Pharmaceutical brand product
• Caladryl
• Fexodina
• Terbifin
• Naprofen
• Neuronox
• Bedoyecta

Products and services

• Sulzinc Humax Pharmaceutical's zinc oxide-based dermatological product brand for topical skin treatment, sold through pharmacies in Colombia.
• Caladryl Loción Topical calamine-based anti-itch lotion product under the Caladryl sub-brand in Humax Pharmaceutical's portfolio, sold through Colombian pharmacies.
• Caladryl Clear Pharmaceutical product variant under the Caladryl sub-brand for dermatological use, sold through Colombian pharmacies.
• Fexodina Humax Pharmaceutical's antihistamine / allergy medication brand sold through Colombian pharmacies for the treatment of allergic conditions.
• Terbifin Humax Pharmaceutical's antifungal medication brand sold through Colombian pharmacies for the treatment of fungal infections.
• Naprofen Humax Pharmaceutical's NSAID / anti-inflammatory pain relief medication brand sold through Colombian pharmacies.
• Neuronox Humax Pharmaceutical's neurological / pain management product brand sold through Colombian pharmacies.
• Bedoyecta Humax Pharmaceutical's B-complex vitamin nutritional supplement brand sold through Colombian pharmacies.

Quantifiable outcome

• More than 250 employees promoted between 2023, 2024, and 2025
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core and minor.

• Bausch Health Companies Inc.coreStrategic or Co-development PartnerHumax Pharmaceutical is a subsidiary (filial) of Bausch Health Companies Inc., a global pharmaceutical company. This provides Humax with access to global resources, pharmaceutical expertise, and international quality standards. Humax operates under the corporate structure and strategic direction of Bausch Health.
• Idiomas EAFITminorStrategic or Co-development PartnerLanguage training partner providing English language education programs for Humax employees. The partnership has yielded results with employees completing C1 level certification, who then motivate others to achieve the same level.
• Aristos Consultores de Gerencia S.A.minorImplementation/ SI/ Consulting PartnerMentoring program partner that has helped train over 30 mentors who accompany employees in their development plans. The partnership strengthens leadership development and career growth initiatives.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sandoz: Global generics and biosimilars company spun out of Novartis; broad OTC and prescription generic footprint across geographies. Comparable through generics-driven business model and OTC franchise strategy though operating globally.
• Teva Pharmaceutical Industries: Global generic pharmaceutical leader with broad OTC, generic, and specialty portfolios. Comparable through its generic-pharma business model and OTC/prescription split, though operating at vastly larger global scale.

Regional players

• EMS: Brazil's largest domestic pharmaceutical company and one of the top generic manufacturers in LATAM, with broad OTC and prescription branded-generic lines. Comparable through portfolio breadth and branded-generic GTM, though Brazil-focused.
• Eurofarma: Brazil-headquartered pan-LATAM pharmaceutical manufacturer with branded generics, OTC, and hospital portfolios. Comparable in business model (branded generics, multi-country LATAM distribution) though geographically anchored to Brazil.
• Bagó: Argentine pharmaceutical group with significant LATAM presence across branded generics, OTC, and specialty therapeutics. Comparable as a LATAM multi-country pharma operator with OTC and ethical portfolios similar to Humax.
• Asofarma: Mexican pharmaceutical company with branded generics, OTC, and consumer health products distributed across Mexico and selected LATAM markets. Similar branded-generic, multi-therapeutic GTM though primarily Mexico-based.

Direct peers

• Procaps: LATAM pharmaceutical contract development and manufacturing organization with branded generic products; comparable as a Colombia-headquartered pharma manufacturer with both OTC and prescription exposure.
• Lafrancol: Colombian pharmaceutical company focused on consumer health, OTC, and personal care products with broad pharmacy distribution — overlapping portfolio categories and distribution channels with Humax in the Colombian market.
• Tecnoquímicas: Colombia's largest domestic pharmaceutical company, manufacturing and marketing branded generics and OTC products across similar therapeutic categories (analgesics, dermatology, vitamins). Directly competes with Humax for shelf space and physician/pharmacy relationships in Colombia.
• Genfar: LATAM-focused generic pharmaceutical manufacturer with strong Colombia presence; competes head-to-head with Humax in the same OTC and prescription generic categories (pain, allergy, dermatology).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Humaxpharmaceutical?locale=es_LA
• LinkedInlinkedin.com/company/humax-pharmaceutical-s.a-
• Instagraminstagram.com/humaxpharmaceutical
• Xx.com/humaxph

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Humax Pharmaceutical